What question did this study set out to answer?

Evaluate the physiological mechanism of angiopoietin-like protein 3 (ANGPTL3) in lipid regulation and review emerging therapeutic inhibitors for cardiovascular disease.

November 29, 2018Circulation JournalOpen Access

ANGPTL3 Inhibitors　― Their Role in Cardiovascular Disease Through Regulation of Lipid Metabolism ―

View Full Paper

Ask AI

Bookmark

Evaluate the physiological mechanism of angiopoietin-like protein 3 (ANGPTL3) in lipid regulation and review emerging therapeutic inhibitors for cardiovascular disease.
Synthesized mechanistic and clinical evidence on ANGPTL family proteins (ANGPTL3, ANGPTL4, and ANGPTL8) in lipoprotein metabolism.
Assessed developmental progress of targeted lipid-lowering therapies, including monoclonal antibodies and antisense oligonucleotides.
ANGPTL3 suppresses lipoprotein lipase and endothelial lipase activity, directly impairing the hydrolysis of circulating triglycerides and phospholipids.
Interaction among ANGPTL3, ANGPTL4, and ANGPTL8 orchestrates the physiological distribution of circulating triglycerides between white adipose tissue and oxidative tissues.
Novel pharmacological inhibitors targeting ANGPTL3 lower circulating atherogenic lipids, showing promise as next-generation interventions for coronary artery disease.

Structured PICO

Population

Patients with hyperlipidemia and cardiovascular disease, as well as animal models (e.g., KK/San mice, ApoE-deficient mice) used to study lipid metabolism.

Intervention

ANGPTL3 inhibitors, including monoclonal antibodies (e.g., evinacumab) and antisense oligonucleotides (ASOs).

ANGPTL3 inhibitors represent a promising novel therapeutic target for the treatment of hyperlipidemia and reduction of cardiovascular disease risk by lowering triglycerides and LDL-C independently of the LDL receptor.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Does not yet alter lipid management; hypothesis-generating for ANGPTL targeting in CAD.

Cite This Study

Geladari et al. (2018) studied this question.

synapsesocial.com/papers/6a70da82a7fbea1e44083beb https://doi.org/10.1253/circj.cj-18-0442

View Full Paper

Ask AI

Bookmark

ANGPTL3 Inhibitors　― Their Role in Cardiovascular Disease Through Regulation of Lipid Metabolism ―

Key Points

Structured PICO

Discussion

Implication

Cite This Study

ANGPTL3 Inhibitors　― Their Role in Cardiovascular Disease Through Regulation of Lipid Metabolism ―

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Also Consider

ANGPTL3 Inhibitors ― Their Role in Cardiovascular Disease Through Regulation of Lipid Metabolism ―

Key Points

Structured PICO

Discussion

Implication

Cite This Study

ANGPTL3 Inhibitors ― Their Role in Cardiovascular Disease Through Regulation of Lipid Metabolism ―

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Also Consider

ANGPTL3 Inhibitors　― Their Role in Cardiovascular Disease Through Regulation of Lipid Metabolism ―

ANGPTL3 Inhibitors　― Their Role in Cardiovascular Disease Through Regulation of Lipid Metabolism ―